Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -38.57% is 67% above its 5-year average of -118.58%, near the high end of its 5-year range (-454.50%–-8.30%).
As of the fiscal period ended Tuesday, June 30, 2026. 27.18% above its 12-month average of -52.96%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -38.57%.
RETURN ON EQUITY (ROE)
-38.57%
RETURN ON EQUITY (ROE) AVG TTM
-52.96%
RETURN ON EQUITY (ROE) AVG 3Y
-112.69%
RETURN ON EQUITY (ROE) AVG 5Y
-118.58%
RETURN ON EQUITY (ROE) AVG 10Y
-50.54%
RETURN ON EQUITY (ROE) AVG 15Y
-18.05%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+27.18%
CURRENT VS 3Y AVG
+65.78%
CURRENT VS 5Y AVG
+67.48%
CURRENT VS 10Y AVG
+23.69%
CURRENT VS 15Y AVG
-113.71%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.15%
median of 341 covered companies
CURRENT VS SECTOR MEDIAN
-32.30%
vs the sector median at left
Canopy Growth Corporation
Market Cap
$373.40M
Return on Equity (ROE)
-38.57%
TTM Avg
-52.96%
3Y Avg
-112.69%
5Y Avg
-118.58%
Market Cap
$368.91M
Return on Equity (ROE)
-7.66%
TTM Avg
-10.18%
3Y Avg
260.20%
5Y Avg
144.75%
Market Cap
$366.39M
Return on Equity (ROE)
-62.56%
TTM Avg
-108.31%
3Y Avg
-79.06%
5Y Avg
-57.33%
Market Cap
$363.54M
Return on Equity (ROE)
N/A
TTM Avg
34.79%
3Y Avg
145.50%
5Y Avg
100.23%
Market Cap
$348.85M
Return on Equity (ROE)
N/A
TTM Avg
-12.63%
3Y Avg
-14.73%
5Y Avg
14.28%
Market Cap
$348.59M
Return on Equity (ROE)
-26.14%
TTM Avg
-53.80%
3Y Avg
-12.25%
5Y Avg
19.21%
Market Cap
$345.48M
Return on Equity (ROE)
-320.77%
TTM Avg
-82.83%
3Y Avg
-78.63%
5Y Avg
-104.90%
Market Cap
$406.47M
Return on Equity (ROE)
-28.18%
TTM Avg
-0.06%
3Y Avg
10.58%
5Y Avg
10.58%
Market Cap
$339.15M
Return on Equity (ROE)
-86.10%
TTM Avg
-112.93%
3Y Avg
-76.30%
5Y Avg
-62.48%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.40M | -38.57% | -52.96% | -112.69% | -118.58% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | -7.66% | -10.18% | 260.20% | 144.75% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | -62.56% | -108.31% | -79.06% | -57.33% |
| Agenus Inc. (AGEN)vs › | $363.54M | N/A | 34.79% | 145.50% | 100.23% |
| Embecta Corp. (EMBC)vs › | $348.85M | N/A | -12.63% | -14.73% | 14.28% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | -26.14% | -53.80% | -12.25% | 19.21% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | -320.77% | -82.83% | -78.63% | -104.90% |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | -28.18% | -0.06% | 10.58% | 10.58% |
| Cabaletta Bio, Inc. (CABA)vs › | $339.15M | -86.10% | -112.93% | -76.30% | -62.48% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | -69.06% | 36.89% | 36.89% | 36.89% |
ROE
-38.6%
ROA
-24.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -38.57% |
| 2026-03-31 | -41.32% |
| 2025-12-31 | -32.69% |
| 2025-09-30 | -51.05% |
| 2025-06-30 | -101.19% |
| 2025-03-31 | -125.81% |
| 2024-12-31 | -82.91% |
| 2024-09-30 | -111.41% |
| 2024-06-30 | -141.89% |
| 2024-03-31 | -132.10% |
| 2023-12-31 | -230.43% |
| 2023-09-30 | -176.68% |
| 2023-06-30 | -198.88% |
| 2023-03-31 | -454.50% |
| 2022-12-31 | -319.91% |
| 2022-09-30 | -280.06% |
| 2022-06-30 | -219.71% |
| 2022-03-31 | -8.30% |
| 2021-12-31 | -12.97% |
| 2021-09-30 | -36.41% |
| 2021-06-30 | -29.20% |
| 2021-03-31 | -49.47% |
| 2020-12-31 | -15.75% |
| 2020-09-30 | 4.08% |
| 2020-06-30 | 10.11% |
| 2020-03-31 | 12.62% |
| 2019-12-31 | -6.63% |
| 2019-09-30 | -3.68% |
| 2019-06-30 | -14.15% |
| 2019-03-31 | -10.35% |
| 2018-12-31 | -6.08% |
| 2018-09-30 | -29.12% |
| 2018-06-30 | -12.55% |
| 2018-03-31 | -5.80% |
| 2017-12-31 | -2.62% |
| 2017-09-30 | -3.47% |
| 2017-06-30 | -2.82% |
| 2017-03-31 | -2.61% |
| 2016-12-31 | -0.34% |
| 2016-09-30 | -4.01% |
| 2016-06-30 | -6.30% |
| 2016-03-31 | -2.71% |
| 2015-12-31 | 0.35% |
| 2015-09-30 | 0.55% |
| 2015-06-30 | -13.42% |
| 2015-03-31 | -19.92% |
| 2014-12-31 | -42.78% |
| 2014-01-31 | -2.15% |
| 2013-10-31 | -12.90% |
| 2013-07-31 | -20.45% |
| 2013-04-30 | -12.77% |
| 2013-01-31 | -13.06% |
| 2012-10-31 | -12.23% |
| 2012-07-31 | -4.02% |
| 2012-04-30 | -3.56% |
| 2012-01-31 | -3.63% |
| 2011-10-31 | -4.33% |
| 2011-07-31 | -4.19% |
| 2011-04-30 | -4.11% |
| 2011-01-31 | -4.40% |
| 2010-10-31 | -5.02% |
